Naokuni Uike

Naokuni Uike publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Naokuni Uike sits on this spectrum.

Naokuni Uike D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Naokuni Uike sits on this spectrum.

Best Publications

• Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

  Takashi Ishida;Tatsuro Joh;Naokuni Uike;Kazuhito Yamamoto

  871
  Citations

• Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma.

  Junichi Kiyasu;Junichi Kiyasu;Hiroaki Miyoshi;Akie Hirata;Fumiko Arakawa

  524
  Citations

• Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma

  Kazuhito Yamamoto;Atae Utsunomiya;Kensei Tobinai;Kunihiro Tsukasaki

  499
  Citations

• Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma.

  Michinori Ogura;Takashi Ishida;Kiyohiko Hatake;Masafumi Taniwaki

  460
  Citations

• Treatment and survival among 1594 patients with ATL

  Hiroo Katsuya;Kenji Ishitsuka;Atae Utsunomiya;Shuichi Hanada

  349
  Citations

• Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma

  Yasushi Yatabe;Ritsuro Suzuki;Kensei Tobinai;Yoshihiro Matsuno

  295
  Citations

• Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients.

  R Kihara;Y Nagata;H Kiyoi;T Kato

  294
  Citations

• Analysis of Genetic Polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese Patients with Therapy-related Leukemia/Myelodysplastic Syndrome and de novo Acute Myeloid Leukemia

  Tomoki Naoe;Kunihiko Takeyama;Toshiya Yokozawa;Hitoshi Kiyoi

  270
  Citations

• Prognostic Index for Acute- and Lymphoma-Type Adult T-Cell Leukemia/Lymphoma

  Hiroo Katsuya;Takeharu Yamanaka;Kenji Ishitsuka;Atae Utsunomiya

  258
  Citations

• Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor

  Yasuo Mori;Hiromi Iwasaki;Kentaro Kohno;Goichi Yoshimoto

  255
  Citations

• Disease evolution and outcomes in familial AML with germline CEBPA mutations

  Kiran Tawana;Jun Wang;Aline Renneville;Aline Renneville;Csaba Bödör

  243
  Citations

• Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma

  Takuya Fukushima;Yasushi Miyazaki;S Honda;F Kawano

  243
  Citations

• Involvement of interferon‐γ and macrophage colony‐stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults

  Koichi Akashi;Shin Hayashi;Hisashi Gondo;Shin-ichi Mizuno

  242
  Citations

• Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study.

  Takashi Ishida;Masakatsu Hishizawa;Koji Kato;Ryuji Tanosaki

  200
  Citations

• Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study

  Kazuo Muroi;Koichi Miyamura;Masaya Okada;Takuya Yamashita

  189
  Citations

• Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study

  T. Igarashi;Y. Kobayashi;M. Ogura;T. Kinoshita

  177
  Citations

• Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies

  S Ogawa;A Hangaishi;S Miyawaki;S Hirosawa

  153
  Citations

• Clinical outcomes of a novel therapeutic vaccine with Tax peptide‐pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study

  Youko Suehiro;Atsuhiko Hasegawa;Tadafumi Iino;Amane Sasada

  146
  Citations

• Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era.

  Ritsuko Seki;Koichi Ohshima;Tomoaki Fujisaki;Naokuni Uike

  141
  Citations

• Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.

  Masami Kuniyoshi;Makoto Nakamuta;Hironori Sakai;Munechika Enjoji

  135
  Citations